General information

Contacts

Industries

Jah

VAT liability

Annual reports

✓

Unsubmitted declarations

???

Credit rating

Tax data

✓

Tax debts

Related persons

Holdings in companies

Statistics

Summary of reports

Licenses

Regulations

Real estate

TTJA decisions

Court decisions

Official announcements

Public transactions

.ee domains

✓

Enforcement proceedings

✓

Payment orders

AS Bravo Pharmaceuticals

Legal form:

Public limited company

Registry code:

14159974

VAT no.:

EE101938974

Fiscal-year period:

01.01 - 31.12

Established:

29.11.2016 (9)

Former business names:

Bravo Pharmaceuticals OÜ

Capital:

163 137 EUR

Address:

Paadi tee 3, Haabneeme alevik, Viimsi vald, Harju maakond, 74001

Status:

Registered

Contacts

Email:

rpandey@bppl.co.in

Phone:

+372 56121500

Industries

HEALTH CARE AND SOCIAL WORK
Health care
Other health activities
8699 - Other human health activities n.e.c.

VAT liability

	Start	End
EE101938974	12.01.2017

Annual reports

Aggregate data

	Period	Submitted
2025	01.01.2025 - 31.12.2025	Due date 30.06.2026
2024	01.01.2024 - 31.12.2024	28.07.2025	Valid
2023	01.01.2023 - 31.12.2023	08.07.2024	Valid
2022	01.01.2022 - 31.12.2022	26.09.2023	Valid
2021	01.01.2021 - 31.12.2021	21.06.2022	Valid
2020	01.01.2020 - 31.12.2020	12.10.2021	Valid
2019	01.01.2019 - 31.12.2019	21.09.2021	Valid
2018	01.01.2018 - 31.12.2018	09.06.2020	Valid
2017	29.11.2016 - 31.12.2017	12.08.2019	Valid

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 05.06.2026.

Delayed declarations

	Deadline	Submitted
Income- and social-tax return	12.01.2026	24.01.2026	12 days overdue
VAT return	20.01.2026	24.01.2026	4 days overdue
Income- and social-tax return	10.11.2025	28.11.2025	18 days overdue
VAT return	20.10.2025	28.11.2025	39 days overdue
VAT return	20.11.2025	28.11.2025	8 days overdue
Income- and social-tax return	10.10.2025	13.10.2025	3 days overdue
VAT return	22.09.2025	06.10.2025	14 days overdue

???

Credit rating

Hidden

Credit rating is based on company financial data and payment behavior. detailed analysis available to regia+ users.

020406080100

? Risk factors

? Strengths

View summary

✓

Tax debt

✓

Unsubmitted reports

✓

Unsubmitted declarations

Court decisions

Official announcements

TTJA decisions

Real estate

.ee domains

Licenses

Regulations

Public transactions

Holdings in companies

✓

Enforcement proceedings

✓

Payment orders

Tax data

	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q1	3 042 €	2 826 €	0 €	2
Kokku 2026:	3 042 €	2 826 €	0 €
2025 Q4	0 €	0 €	0 €	1
2025 Q3	1 743 €	1 651 €	0 €	1
2025 Q2	6 288 €	5 656 €	0 €100.0%	1
2025 Q1	4 324 €	2 901 €	3 443 €36.5%	1
Kokku 2025:	12 355 €	10 208 €	3 443 €89.6%
2024 Q4	4 683 €	4 025 €	5 421 €	1
2024 Q3	5 223 €	4 571 €	0 €100.0%	1
2024 Q2	7 415 €	4 844 €	17 100 €60.2%	1
2024 Q1	7 013 €	4 791 €	10 674 €26.7%	1
Kokku 2024:	24 334 €	18 231 €	33 195 €128.0%
2023 Q4	7 123 €	4 685 €	14 557 €	1
2023 Q3	6 808 €	5 697 €	0 €	1
2023 Q2	4 141 €	3 637 €	0 €	1
2023 Q1	5 485 €	4 591 €	0 €	1
Kokku 2023:	23 557 €	18 610 €	14 557 €26.4%
2022 Q4	5 519 €	4 614 €	0 €	1
2022 Q3	5 376 €	4 574 €	0 €100.0%	1
2022 Q2	5 377 €	4 574 €	4 000 €74.6%	1
2022 Q1	5 453 €	4 574 €	15 775 €294.4%	1
Kokku 2022:	21 726 €	18 336 €	19 775 €30.5%
2021 Q4	5 528 €	4 620 €	4 000 €33.8%	1
2021 Q3	5 011 €	4 028 €	6 042 €18.1%	1
2021 Q2	4 476 €	3 754 €	5 117 €	1
2021 Q1	4 136 €	3 754 €	0 €	2
Kokku 2021:	19 152 €	16 157 €	15 158 €72.1%
2020 Q4	4 076 €	3 766 €	0 €100.0%	2
2020 Q3	2 903 €	3 537 €	17 024 €114.6%	2
2020 Q2	5 483 €	4 136 €	7 933 €73.0%	2
2020 Q1	2 338 €	2 068 €	29 333 €	2
Kokku 2020:	14 801 €	13 506 €	54 291 €163.6%
2019 Q4	2 407 €	2 479 €	0 €	2
2019 Q3	1 698 €	1 743 €	0 €100.0%	2
2019 Q2	2 568 €	2 624 €	18 012 €597.3%	2
2019 Q1	933 €	795 €	2 583 €94.5%	2
Kokku 2019:	7 606 €	7 641 €	20 595 €81.5%
2018 Q4	1 650 €	1 693 €	46 910 €57.3%	2
2018 Q3	1 650 €	1 693 €	29 820 €	2
2018 Q2	2 431 €	2 479 €	0 €100.0%	2
2018 Q1	2 623 €	605 €	34 617 €	2
Kokku 2018:	8 354 €	6 470 €	111 347 €
2017 Q4	158 €	165 €	0 €	1
2017 Q3	0 €	0 €	0 €	0
2017 Q2	0 €	0 €	0 €	0
2017 Q1	0 €	0 €	0 €	0
Kokku 2017:	158 €	165 €	0 €

Revenue by industry

	2022	2023	2024
Other human health activities n.e.c.			28 873 €
Other human health activities n.e.c.	4 775 €	19 945 €

Tax debts

No tax debt found

No tax debt as of 05.06.2026

Representatives

Name	Personal ID code	Date of birth	Role	Start	End
Reena Singh	47803XXXXXX	13.03.1978 (48)	Board member	21.12.2018	-
Rakesh Pandey	37712XXXXXX	10.12.1977 (48)	Board member	29.11.2016	-

1 - 2 / 2 rows

Shareholders

Name	Personal ID code	Date of birth	Role	Share	%	Type	Start	End
Rakesh Pandey	37712XXXXXX	10.12.1977 (48)	Shareholder	129 975,00 EUR	79,67	Sole ownership	28.02.2025	-
Reena Singh	47803XXXXXX	13.03.1978 (48)	Shareholder	33 162,00 EUR	20,33	Sole ownership	28.02.2025	-

14 inactive record hidden, extended access to the information portal is required to view history!

1 - 2 / 2 rows

Other persons

Name	Personal ID code	Date of birth	Role	Start	End
Kamlesh Patel	-	29.11.1958 (67)	Supervisory-board member	24.07.2020	-
Ivo Nagel	37709XXXXXX	07.09.1977 (48)	Chairman of the supervisory board	13.11.2018	-
Audiitorbüroo Katrin Mugra OÜ	-	-	Audit firm	28.12.2017	-
Nishant Kumar	38310XXXXXX	18.10.1983 (42)	Supervisory-board member	20.12.2017	-
Rakesh Pandey	37712XXXXXX	10.12.1977 (48)	Founder	02.11.2016	-

2 inactive record hidden, extended access to the information portal is required to view history!

1 - 5 / 5 rows

Ultimate beneficial owners

Name	Personal ID code	Date of birth	Role	Start	End
Rakesh Pandey	37712XXXXXX	10.12.1977 (48)	Direct holding	11.08.2019	-
Reena Singh	47803XXXXXX	13.03.1978 (48)	Direct holding	11.08.2019	-

1 - 2 / 2 rows

Holdings in companies

Company	Registered	Role	Share	%	Type	Start	End
Competence Centre for Cancer Research AS	13.02.2004	Shareholder	32 500,00 EUR	65	Sole ownership	16.08.2023	-

1 - 1 / 1 rows

2026 Q1

Turnover

Amount

0 €

Monthly average

0 €

Per employee

0 €

Equity ratio

Labour taxes

Turnover ratio

0,00%

Tax ratio

92,90%

Monthly average

942 €

Per employee

628 €

State taxes

Monthly average

1 014 €

Turnover ratio

0,00%

Estimated salary

Gross salary

1 299 €

Net salary

1 111 €

Aggregate data

	2024	2023	2022	2021	2020	2019
Current assets	46 661 €18.9%	57 561 €1.4%	56 781 €9.0%	62 375 €31.4%	47 456 €51.1%	96 961 €
Non-current assets	237 898 €1.5%	241 511 €3.6%	250 602 €6.0%	266 505 €6.0%	251 515 €259.6%	69 942 €
Total assets	284 559 €4.9%	299 072 €2.7%	307 383 €6.5%	328 880 €10.0%	298 971 €79.1%	166 903 €
Short-term liabilities	242 772 €30.4%	186 118 €70.4%	109 217 €24.0%	143 729 €154.4%	56 507 €560.6%	8 554 €
Long-term liabilities	-	-	-	-	-	40 042 €
Total liabilities	242 772 €30.4%	186 118 €70.4%	109 217 €24.0%	143 729 €154.4%	56 507 €16.3%	48 596 €
Share or stock capital	335 337 €105.3%	163 337 €	163 337 €225.4%	50 200 €	50 200 €0.4%	50 000 €
Retained earnings	-222 383 €738.5%	34 829 €74.2%	134 951 €29.8%	192 264 €20.0%	240 307 €157.7%	93 266 €
Net profit	-71 167 €16.5%	-85 212 €14.9%	-100 122 €74.7%	-57 313 €19.3%	-48 043 €92.5%	-24 959 €
Equity	41 787 €63.0%	112 954 €43.0%	198 166 €7.0%	185 151 €23.6%	242 464 €104.9%	118 307 €
Turnover	28 873 €44.8%	19 945 €317.7%	4 775 €84.2%	30 158 €42.5%	52 458 €133.9%	22 429 €
Profit margin	-246.48%42.3%	-427.23%79.6%	-2 096.80%1 003.3%	-190.04%107.5%	-91.58%17.7%	-111.28%

Financial ratios

	2024	2023	2022	2021	2020
Profit and cash flow
EBITDA	-QN OZZ	-WU IMS	-MA OXV	-54 727	-40 914
Liquidity
Current ratio	H.C	X.G	L.S	0.4	0.8
Quick ratio	V.F	D.N	I.Q	0.4	0.8
Cash ratio	X.F	L.K	F.Y	0.0	0.0
Efficiency
Days sales outstanding (dso)	IFC.Q	U WTY.T	P EVC.U	633.7	498.0
Asset turnover	K.F	C.K	D.X	0.1	0.2
Structure
Debt ratio	V.Y	U.I	Q.A	0.4	0.2
Profitability
Operating margin	-MXP.K%	-ZHF.E%	-Z RJS.J%	-190.5%	-81.2%
Net profit margin	-CAQ.Z%	-XYQ.M%	-Q FTN.K%	-190.0%	-91.6%
Return on assets (roa)	-FD.G%	-RG.H%	-GX.R%	-18.3%	-20.6%
Return on equity (roe)	-EYF.H%	-SO.T%	-WL.F%	-31.0%	-19.8%

To view all financial ratios, you need to subscribe to extended access to the info portal!

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations

Regulation no.	Date	Type	Deadline	Status
Ä 50042263 / M4	15.07.2025	Fine-warning order – annual report not filed	27.08.2025	Deficiencies remedied (29.07.2025)
Ä 50042263 / 14	21.02.2025	Entry - Amendment entry		Entered into force (21.02.2025)
Ä 50042263 / 13	19.09.2024	Entry - Amendment entry		Entered into force (19.09.2024)
Ä 50042263 / M3	01.08.2024	Order to remedy deficiencies - Amendment entry	14.09.2024	Deficiencies remedied (12.09.2024)
Ä 50042263 / M2	07.07.2024	Fine-warning order – annual report not filed	06.08.2024	Deficiencies remedied (09.07.2024)

1 - 5 / 18 rows

Real estate

No real estate found

Company has no real estate

1 inactive record hidden, extended access to the information portal is required to view history!

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Official announcements

Subject	Date
Notice of delivery of a Tax-and-Customs-Board document	05.11.2025
Notice of delivery of a Tax-and-Customs-Board document	01.08.2025
Notice of share-capital reduction	26.09.2024

AS Bravo Pharmaceuticals

Contacts

Industries

VAT liability

Annual reports

Unsubmitted declarations

No unsubmitted declarations found

Delayed declarations

Credit rating

Hidden

Tax data

Revenue by industry

Tax debts

No tax debt found

Representatives

Shareholders

Other persons

Ultimate beneficial owners

Holdings in companies

Holdings in companies

Aggregate data

Financial ratios

Licences & notices

No licenses and notices found

Regulations

Regulations

Real estate

No real estate found

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Official announcements

Official announcements

Public transactions

No public transactions found

.ee domains

No domains found

Enforcement proceedings

No enforcement proceedings found

Payment orders

No payment orders found